HOFSETH BIOCARE ASA (HBC.OL) Stock Income Statement
OSL:HBC - Euronext Oslo - NO0010598683 - Common Stock - Currency: NOK
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 257.42M | 194.87M | 120.45M | 87.62M | 69.25M | |||
| Minority Interest Expense | 2.00K | 1.00K | 1.00K | 1.00K | 1.00K | |||
| Cost Of Goods | 169.55M | 150.69M | 91.93M | 85.11M | 55.59M | |||
| Gross Profit | 87.86M | 44.19M | 28.51M | 2.51M | 13.66M | |||
| Operating Expenses | 199.70M | 167.70M | 155.68M | 118.72M | 103.77M | |||
| Research and Development | 9.32M | 11.01M | 13.63M | 8.87M | 7.56M | |||
| Selling, General, and Administrative Expenses | 86.00M | 71.76M | 72.08M | 57.74M | 50.50M | |||
| Operating Income | -111.83M | -123.52M | -127.17M | -116.21M | -90.11M | |||
| Interest Income/Expense | -20.22M | -4.16M | -8.77M | -7.90M | -9.76M | |||
| Other Income/Expense | -1.00K | -1.00K | -3.18M | 0.00 | -315.00K | |||
| Non Recurring Items | 6.75M | 20.99M | -1.45M | -2.35M | -1.91M | |||
| Income Before Taxes | -125.30M | -106.68M | -137.39M | -126.46M | -102.09M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -125.30M | -106.68M | -137.39M | -126.46M | -102.09M | |||
| EBITDA | -72.05M | -87.10M | -96.75M | -86.86M | -63.35M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.30 | -0.27 | -0.37 | -0.35 | -0.31 | |||
| Statistics | ||||||||
| Gross Profit Margin | 34.13% | 22.68% | 23.67% | 2.86% | 19.73% | |||
| Profit Margin | -48.68% | -54.74% | -114.06% | -144.34% | -147.42% | |||
| Operating Profit Margin | -43.44% | -63.38% | -105.58% | -132.64% | -130.12% | |||
All data in NOK